Turoctocog alfa pegol clinical trials
Also written N8-GP.
How each study uses turoctocog alfa pegol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 19 Feb 2019 · Esperoct · BLA 125671 (FDA, Purple Book)
- European Union
- 20 Jun 2019 · Esperoct · EMEA/H/C/004883 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Studies
Open first, then newest update. How each study uses turoctocog alfa pegol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)CompletedPhase 3Novo Nordisk A/SNCT05082116Written as turoctocog alfa pegol (N8-GP)
- Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia ACompletedPhase 3Novo Nordisk A/SNCT02137850Written as turoctocog alfa pegol
- A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia ACompletedPhase 3Novo Nordisk A/SNCT03528551Written as Turoctocog alfa pegol
- Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia ACompletedPhase 3Novo Nordisk A/SNCT01480180Written as turoctocog alfa pegol
- A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia ACompletedPhase 3Novo Nordisk A/SNCT01731600Written as turoctocog alfa pegol
- Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A.CompletedPhase 3Novo Nordisk A/SNCT01489111Written as turoctocog alfa pegol
- Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia ACompletedPhase 1Novo Nordisk A/SNCT02994407Written as turoctocog alfa pegol
- A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia ACompletedPhase 1Novo Nordisk A/SNCT02920398Written as turoctocog alfa pegol
- Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia ACompletedPhase 1Novo Nordisk A/SNCT01205724Written as turoctocog alfa pegol
Codes
What other systems call turoctocog alfa pegol · ClinicalTrials.gg INT015935
- UNII (FDA) 9Y9727LS4DTUROCTOCOG ALFA PEGOLConfirmed FDA, Wikidata
- Wikidata Q106712968turoctocog alfa pegolConfirmed FDA, Wikidata
- NCI Thesaurus C152786Turoctocog Alfa PegolOne source FDA
- DrugBank DB14738One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 9Y9727LS4D | TUROCTOCOG ALFA PEGOL | Confirmed FDA, Wikidata |
| Wikidata | Q106712968 | turoctocog alfa pegol | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152786 | Turoctocog Alfa Pegol | One source FDA |
| DrugBank | DB14738 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.